|
Volumn 22, Issue 4, 2001, Pages 177-181
|
Sequential intensified immunosuppressive therapy combining with hematopoietic growth factors in the treatment of severe aplastic anemia
a a a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CYCLOSPORIN;
HEMOPOIETIC GROWTH FACTOR;
IMMUNOSUPPRESSIVE AGENT;
LYMPHOCYTE ANTIBODY;
ADOLESCENT;
ADULT;
APLASTIC ANEMIA;
ARTICLE;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG COMBINATION;
FEMALE;
HUMAN;
MALE;
MIDDLE AGED;
MORTALITY;
PRESCHOOL CHILD;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
ANEMIA, APLASTIC;
ANTILYMPHOCYTE SERUM;
CHILD;
CHILD, PRESCHOOL;
CYCLOSPORINE;
DRUG THERAPY, COMBINATION;
FEMALE;
HEMATOPOIETIC CELL GROWTH FACTORS;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
TREATMENT OUTCOME;
YOUNG ADULT;
|
EID: 66049163949
PISSN: 02532727
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (0)
|